164 related articles for article (PubMed ID: 36840340)
1. Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities.
Tornatore KM; Attwood K; Venuto RC; Murray B
Clin Transl Sci; 2023 May; 16(5):861-871. PubMed ID: 36840340
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus and Mycophenolic Acid Exposure Are Associated with Biopsy-Proven Acute Rejection: A Study to Provide Evidence for Longer-Term Target Ranges.
Meziyerh S; van Gelder T; Kers J; van der Helm D; van der Boog PJM; de Fijter JW; Moes DJAR; de Vries APJ
Clin Pharmacol Ther; 2023 Jul; 114(1):192-200. PubMed ID: 37082913
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
[TBL] [Abstract][Full Text] [Related]
4. Influence of Calcineurin Inhibitor and Sex on Mycophenolic Acid Pharmacokinetics and Adverse Effects Post-Renal Transplant.
Meaney CJ; Sudchada P; Consiglio JD; Wilding GE; Cooper LM; Venuto RC; Tornatore KM
J Clin Pharmacol; 2019 Oct; 59(10):1351-1365. PubMed ID: 31062373
[TBL] [Abstract][Full Text] [Related]
5. Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients.
Tornatore KM; Meaney CJ; Attwood K; Brazeau DA; Wilding GE; Consiglio JD; Gundroo A; Chang SS; Gray V; Cooper LM; Venuto RC
Pharmacotherapy; 2022 Feb; 42(2):94-105. PubMed ID: 35103348
[TBL] [Abstract][Full Text] [Related]
6. Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients.
Tornatore KM; Meaney CJ; Wilding GE; Chang SS; Gundroo A; Cooper LM; Gray V; Shin K; Fetterly GJ; Prey J; Clark K; Venuto RC
Clin Pharmacokinet; 2015 Apr; 54(4):423-34. PubMed ID: 25511793
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation.
Sobiak J; Resztak M; Głyda M; Szczepaniak P; Chrzanowska M
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):331-8. PubMed ID: 25663618
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients.
Wang XH; Shao K; An HM; Zhai XH; Zhou PJ; Chen B
Eur J Clin Pharmacol; 2022 Aug; 78(8):1261-1272. PubMed ID: 35536394
[TBL] [Abstract][Full Text] [Related]
9. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
[TBL] [Abstract][Full Text] [Related]
10. Influence of Calcineurin Inhibitors and Genetic Polymorphism of Transporters on Enterohepatic Circulation and Exposure of Mycophenolic Acid in Chinese Adult Renal Allograft Recipients.
Sun SS; Shao K; Lu JQ; An HM; Shi HQ; Zhou PJ; Chen B
J Clin Pharmacol; 2023 Apr; 63(4):410-420. PubMed ID: 36394393
[TBL] [Abstract][Full Text] [Related]
11. Association of ABCC2 Haplotypes to Mycophenolic Acid Pharmacokinetics in Stable Kidney Transplant Recipients.
Brazeau D; Meaney CJ; Consiglio JD; Wilding GE; Cooper LM; Venuto RC; Tornatore KM
J Clin Pharmacol; 2021 Dec; 61(12):1592-1605. PubMed ID: 34169529
[TBL] [Abstract][Full Text] [Related]
12. Defining algorithms for efficient therapeutic drug monitoring of mycophenolate mofetil in heart transplant recipients.
Kaczmarek I; Bigdeli AK; Vogeser M; Mueller T; Beiras-Fernandez A; Kaczmarek P; Schmoeckel M; Meiser B; Reichart B; Ueberfuhr P
Ther Drug Monit; 2008 Aug; 30(4):419-27. PubMed ID: 18641552
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolic acid 12-hour area under the curve in de novo liver transplant patients given mycophenolate mofetil at fixed versus concentration-controlled doses.
Kamar N; Marquet P; Gandia P; Muscari F; Lavayssière L; Esposito L; Guitard J; Canivet C; Peron JM; Alric L; Suc B; Saint-Marcoux F; Rostaing L
Ther Drug Monit; 2009 Aug; 31(4):451-6. PubMed ID: 19531983
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Mycophenolate Mofetil Metabolites in Older Patients on the Seventh Day After Renal Transplantation.
Sobiak J; Głyda M; Malec M; Chrzanowska M
Transplant Proc; 2021 Sep; 53(7):2212-2215. PubMed ID: 34412913
[TBL] [Abstract][Full Text] [Related]
16. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation.
Naito T; Shinno K; Maeda T; Kagawa Y; Hashimoto H; Otsuka A; Takayama T; Ushiyama T; Suzuki K; Ozono S
Biol Pharm Bull; 2006 Feb; 29(2):275-80. PubMed ID: 16462031
[TBL] [Abstract][Full Text] [Related]
17. Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations Are Associated with the Stool Bacterial Microbiome after Hematopoietic Cell Transplantation.
Saqr A; Carlson B; Staley C; Rashidi A; Al-Kofahi M; Kaiser T; Holtan S; MacMillan M; Young JA; Jurdi NE; Weisdorf D; Khoruts A; Jacobson PA
Transplant Cell Ther; 2022 Jul; 28(7):372.e1-372.e9. PubMed ID: 35489611
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
[TBL] [Abstract][Full Text] [Related]
19. Early Immunosuppressive Exposure of Enteric-Coated-Mycophenolate Sodium Plus Tacrolimus Associated with Acute Rejection in Expanded Criteria Donor Kidney Transplantation.
Ding CG; Jiao LZ; Han F; Xiang HL; Tian PX; Ding XM; Pan XM; Tian XH; Li Y; Zheng J; Xue WJ
Chin Med J (Engl); 2018 Jun; 131(11):1302-1307. PubMed ID: 29786042
[TBL] [Abstract][Full Text] [Related]
20. The impact of tacrolimus exposure on extrarenal adverse effects in adult renal transplant recipients.
Campagne O; Mager DE; Brazeau D; Venuto RC; Tornatore KM
Br J Clin Pharmacol; 2019 Mar; 85(3):516-529. PubMed ID: 30414331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
